Cellectar Biosciences Price to Free Cash Flow Ratio 2010-2024 | CLRB
Historical price to free cash flow ratio values for Cellectar Biosciences (CLRB) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cellectar Biosciences Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-02-21 | 0.31 | 0.00 | |
| 2024-09-30 | 2.14 | $-1.58 | 0.00 |
| 2024-06-30 | 2.50 | $-2.15 | 0.00 |
| 2024-03-31 | 3.98 | $-2.54 | 0.00 |
| 2023-12-31 | 2.77 | $-2.72 | 0.00 |
| 2023-09-30 | 2.64 | $-2.74 | 0.00 |
| 2023-06-30 | 1.95 | $-3.13 | 0.00 |
| 2023-03-31 | 1.43 | $-3.42 | 0.00 |
| 2022-12-31 | 1.71 | $-3.61 | 0.00 |
| 2022-09-30 | 3.36 | $-4.01 | 0.00 |
| 2022-06-30 | 4.04 | $-3.67 | 0.00 |
| 2022-03-31 | 6.88 | $-3.93 | 0.00 |
| 2021-12-31 | 6.64 | $-4.09 | 0.00 |
| 2021-09-30 | 9.25 | $-6.24 | 0.00 |
| 2021-06-30 | 11.90 | $-4.48 | 0.00 |
| 2021-03-31 | 16.10 | $7.22 | 2.23 |
| 2020-12-31 | 20.80 | $2.56 | 8.13 |
| 2020-09-30 | 12.40 | $4.04 | 3.07 |
| 2020-06-30 | 12.80 | $1.12 | 11.42 |
| 2019-12-31 | 22.50 | $-15.27 | 0.00 |
| 2019-09-30 | 20.00 | $-22.19 | 0.00 |
| 2019-06-30 | 21.80 | $-14.52 | 0.00 |
| 2019-03-31 | 23.50 | $-26.70 | 0.00 |
| 2018-12-31 | 15.50 | $-39.74 | 0.00 |
| 2018-09-30 | 30.00 | $-44.78 | 0.00 |
| 2018-06-30 | 62.00 | $-69.75 | 0.00 |
| 2018-03-31 | 113.50 | $-74.54 | 0.00 |
| 2017-12-31 | 137.00 | $-81.01 | 0.00 |
| 2017-09-30 | 167.00 | $-144.10 | 0.00 |
| 2017-06-30 | 163.00 | $-149.64 | 0.00 |
| 2017-03-31 | 227.00 | $-16.15 | 0.00 |
| 2016-12-31 | 122.00 | $-191.33 | 0.00 |
| 2016-09-30 | 271.00 | $-274.86 | 0.00 |
| 2016-06-30 | 344.00 | $-1,140.05 | 0.00 |
| 2016-03-31 | 341.83 | $-1,258.37 | 0.00 |
| 2015-12-31 | 735.00 | $-1,348.06 | 0.00 |
| 2015-09-30 | 1970.00 | $-1,500.10 | 0.00 |
| 2020-03-31 | 13.33 | $-1,201.55 | 0.00 |
| 2015-06-30 | 2880.00 | $-929.02 | 0.00 |
| 2015-03-31 | 3110.00 | $-1,338.28 | 0.00 |
| 2014-12-31 | 3090.00 | $-1,931.35 | 0.00 |
| 2014-09-30 | 2220.00 | $-2,364.69 | 0.00 |
| 2014-06-30 | 6390.00 | $-3,537.99 | 0.00 |
| 2014-03-31 | 7800.00 | $-3,464.71 | 0.00 |
| 2013-12-31 | 7400.00 | $-3,328.25 | 0.00 |
| 2013-09-30 | 7200.00 | $-3,276.90 | 0.00 |
| 2013-06-30 | 9200.00 | $-4,649.33 | 0.00 |
| 2013-03-31 | 9200.00 | $-4,023.08 | 0.00 |
| 2012-12-31 | 14800.00 | $-3,250.26 | 0.00 |
| 2012-09-30 | 21000.00 | $-2,277.13 | 0.00 |
| 2012-06-30 | 23800.00 | $-0.22 | 0.00 |
| 2012-03-31 | 17000.00 | $-0.28 | 0.00 |
| 2011-12-31 | 8800.00 | $-0.25 | 0.00 |
| 2011-09-30 | 25400.00 | $-866.76 | 0.00 |
| 2011-06-30 | 26000.00 | $-866.76 | 0.00 |
| 2011-03-31 | 61200.00 | $-863.11 | 0.00 |
| 2010-12-31 | 91800.00 | $-866.85 | 0.00 |
| 2010-09-30 | 153000.00 | $-0.26 | 0.00 |
| 2010-06-30 | 336600.00 | $-0.21 | 0.00 |
| 2010-03-31 | 550800.00 | $-3.76 | 0.00 |
| 2009-12-31 | 7772400.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.015B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.977B | 28.52 |
| Boston Scientific (BSX) | United States | $155.488B | 41.98 |
| Stryker (SYK) | United States | $147.446B | 31.70 |
| EssilorLuxottica (ESLOY) | France | $140.780B | 0.00 |
| Medtronic (MDT) | Ireland | $112.764B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.084B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.818B | 29.12 |
| GE HealthCare Technologies (GEHC) | United States | $42.113B | 20.51 |
| Agilent Technologies (A) | United States | $39.025B | 25.86 |
| ResMed (RMD) | United States | $34.189B | 26.33 |
| Terumo (TRUMY) | Japan | $26.310B | 37.41 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.630B | 12.95 |
| Insulet (PODD) | United States | $20.222B | 86.57 |
| Baxter (BAX) | United States | $17.074B | 12.34 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.245B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.513B | 35.65 |
| Bio-Rad Laboratories (BIO) | United States | $8.001B | 27.70 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 13.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.200B | 20.05 |
| ICU Medical (ICUI) | United States | $3.995B | 38.03 |
| Envista Holdings (NVST) | United States | $3.693B | 29.38 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.188B | 15.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.921B | 19.69 |
| QuidelOrtho (QDEL) | United States | $2.760B | 23.18 |
| LeMaitre Vascular (LMAT) | United States | $2.269B | 55.15 |
| Neogen (NEOG) | United States | $2.178B | 25.10 |
| AtriCure (ATRC) | United States | $1.914B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.90 |
| InMode (INMD) | Israel | $1.320B | 11.03 |
| BioLife Solutions (BLFS) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.180B | 8.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.997B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.938B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.930B | 14.27 |
| Evolus (EOLS) | United States | $0.926B | 0.00 |
| CeriBell (CBLL) | United States | $0.828B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.689B | 0.00 |
| Valneva SE (VALN) | France | $0.643B | 0.00 |
| Omeros (OMER) | United States | $0.557B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.494B | 3.86 |
| Surmodics (SRDX) | United States | $0.492B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.321B | 58.60 |
| Viemed Healthcare (VMD) | United States | $0.310B | 29.52 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Biote (BTMD) | United States | $0.260B | 5.69 |
| Canopy Growth (CGC) | Canada | $0.250B | 0.00 |
| Zynex (ZYXI) | United States | $0.236B | 49.40 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| Brainsway (BWAY) | Israel | $0.212B | 112.80 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.39 |
| MacroGenics (MGNX) | United States | $0.181B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 12.79 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| InterCure (INCR) | Israel | $0.075B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Exagen (XGN) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.058B | 30.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| MariMed (MRMD) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.22 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| INLIF (INLF) | $0.040B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |